Palvella Therapeutics (PVLA) Net Income (QoQ) (2013 - 2026)
Palvella Therapeutics (PVLA) Net Income (QoQ) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,440.76 Bn | 66,440.47 Bn | - |
| 2 | Nanobiotix | 1,880.51 Bn | 1,880.45 Bn | - |
| 3 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - |
| 4 | BeOne Medicines | 467.94 Bn | 463.15 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.63 Bn | 115.38 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.30 Bn | 61.54 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.81 Bn | 62.81 Bn | - |
| 8 | Argenx Se | 55.78 Bn | 50.59 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.33 Bn | 34.32 Bn | 959.66 Mn |
| 10 | Palvella Therapeutics | 1.85 Bn | 1.59 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -23.39% |
| Dec 31, 2025 | -12.63% |
| Sep 30, 2025 | -19.79% |
| Jun 30, 2025 | -15.71% |
| Mar 31, 2025 | -107.16% |
| Dec 31, 2024 | 41.68% |
| Sep 30, 2024 | -62.39% |
| Jun 30, 2024 | -64.51% |
| Mar 31, 2024 | -116.92% |
| Dec 31, 2023 | 221.77% |
| Sep 30, 2023 | -887.40% |
| Jun 30, 2023 | 109.76% |
| Mar 31, 2023 | -29.97% |
| Dec 31, 2022 | 2.75% |
| Sep 30, 2022 | 2.03% |
| Jun 30, 2022 | -60.48% |
| Mar 31, 2022 | 31.13% |
| Dec 31, 2021 | 40.35% |
| Sep 30, 2021 | -12.97% |
| Jun 30, 2021 | -201.46% |